作者:
Markus,Zeitlinger [1]
;
Birgit C P,Koch [2]
;
Roger,Bruggemann [3]
;
Pieter,De Cock [4]
;
Timothy,Felton [5]
;
Maya,Hites [6]
;
Jennifer,Le [7]
;
Sonia,Luque [8]
;
Alasdair P,MacGowan [9]
;
Deborah J E,Marriott [10]
;
Anouk E,Muller [11]
;
Kristina,Nadrah [12]
;
David L,Paterson [13]
;
Joseph F,Standing [14]
;
João P,Telles [15]
;
Michael,Wölfl-Duchek [16]
;
Michael,Thy [17]
;
Jason A,Roberts [18]
;
PK/PD of Anti-Infectives Study Group (EPASG) of the European Society of Clinical Microbiology, Infectious Diseases (ESCMID) [19]
作者单位:
Department of Clinical Pharmacology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. markus.zeitlinger@meduniwien.ac.at.
[1]
Hospital Pharmacy, Erasmus MC, Rotterdam, The Netherlands.
[2]
Radboud University Medical Center, Nijmegen, The Netherlands.
[3]
Department of Pharmacy 2, Heymans Institute of Pharmacology, Ghent University Hospital, Ghent University, Ghent, Belgium.
[4]
Division of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
[5]
Intensive Care Unit, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
[6]
Clinic of Infectious Diseases, CUB-Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.
[7]
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, San Diego, CA, USA.
[8]
Pharmacy Department, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain.
[9]
Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar D'Investigacions Mèdiques (IMIM), Barcelona, Spain.
[10]
Bristol Centre for Antimicrobial Research and Evaluation, Infection Sciences, Severn Pathology Partnership, North Bristol NHS Trust, Southmead Hospital, Westbury-On-Trym, Bristol, UK.
[11]
St. Vincent's Hospital, Darlinghurst, NSW, Australia.
[12]
University of New South Wales, Sydney, NSW, Australia.
[13]
HaaglandenMC, The Hague and ErasmusMC, Rotterdam, The Netherlands.
[14]
Department of Infectious Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia.
[15]
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
[16]
University of Queensland Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
[17]
Department of Infectious Diseases, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.
[18]
Infection, Inflammation and Immunity, Great Ormond Street Institute of Child Health, University College London, London, UK.
[19]
Department of Pharmacy, Great Ormond Street Hospital for Children, London, UK.
[20]
Department of Infectious Diseases, AC Camargo Cancer Center, São Paulo, SP, Brazil.
[21]
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
[22]
Infectious Diseases Department and Intensive Care Unit, Hospital Bichat, Paris, France.
[23]
EA7323, Evaluation of Perinatal and Paediatric Therapeutics and Pharmacology, University Paris Descartes, Paris, France.
[24]
University of Queensland Centre for Clinical Research, Faculty of Medicine and Centre for Translational Anti-Infective Pharmacodynamics, School of Pharmacy, The University of Queensland, Brisbane, QLD, Australia. j.roberts2@uq.edu.au.
[25]
Department of Pharmacy, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia. j.roberts2@uq.edu.au.
[26]
Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia. j.roberts2@uq.edu.au.
[27]
Division of Anaesthesiology Critical Care Emergency and Pain Medicine, Nîmes University Hospital, University of Montpellier, Nîmes, France. j.roberts2@uq.edu.au.
[28]
The University of Queensland Centre for Clinical Research, The University of Queensland, Royal Brisbane and Women's Hospital, Butterfield St, Herston, QLD, 4029, Australia. j.roberts2@uq.edu.au.
[29]
DOI
10.1007/s40262-020-00924-9
PMID
32725382
发布时间
2023-11-12